Page 116 - HIV/AIDS Guidelines

22. Fox Z, Phillips A, Cohen C, et al. Viral resuppression and detection of drug resistance following interruption of a
suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS. 2008;22(17):2279-2289.
23. Bessesen M, Ives D, Condreay L, et al. Chronic active hepatitis B exacerbations in human immunodeficiency virus-
infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis.
1999;28(5):1032-1035.
24. Sellier P, Clevenbergh P, Mazeron MC, et al. Fatal interruption of a 3TC-containing regimen in a HIV-infected patient
due to re-activation of chronic hepatitis B virus infection. Scand J Infect Dis. 2004;36(6-7):533-535.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents H-23

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.